Fatty liver disease (MASLD/MASH) trials in Hungary
5 trials · From ClinicalTrials.gov, checked 10 Nov 2026. Ask the study team whether a trial fits you.
Phase 3RecruitingTrial-stage medicine
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
- Where
- Bekescsaba, Budapest, Budapest III, Budapest IX
- Age
- 18 years and over
- People
- 1,800 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06632444EU 2024-513739-25-00Registry updated 2026-10-28
Phase 3RecruitingTrial-stage medicine
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
- Where
- Bekescsaba, Budapest, Budapest III, Budapest IX
- Age
- 18 years and over
- People
- 1,590 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06632457EU 2024-513741-36-00Registry updated 2026-10-28
Phase 3RecruitingTrial-stage medicine
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- Where
- Budapest, Budapest II, Budapest IX
- Age
- 18 years to 75 years
- People
- 1,800 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT06419374EU 2023-510395-31-00Registry updated 2026-10-23
Phase 3RecruitingTrial-stage medicine
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
- Where
- Budapest, Debrecen, Nyíregyháza
- Age
- 18 years and over
- People
- 4,500 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07165028EU 2025-522674-36-00Registry updated 2026-10-08
No phaseRecruitingResearch participation
Cardiovascular Risk in Children With Chronic Conditions Study
- Where
- Budapest
- Age
- 6 years to 25 years
- People
- 300
- Run by
- Semmelweis University
See details and how to joinNCT07086989Registry updated 2025-08-08
All Fatty liver disease (MASLD/MASH) trials and the map
This page is not medical advice. Talk to your doctor before contacting a trial.